secwatch.observer — SEC 8-K summary
======================================

Issuer:     TG THERAPEUTICS, INC. (TGTX)
CIK:        0001001316
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0001437749-25-020335
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TG Therapeutics annual meeting: all proposals pass; say-on-pay gets 54.5% support, director Lonial 54.1%
--------------------------------------------------------------------------------

- Six directors elected; Sagar Lonial, MD had lowest support (54.12% for, 40.5M withheld).
- KPMG ratified as independent auditor for FY2025 with 117.8M for (99.6% approval).
- Advisory vote on named executive officer compensation passed with 47.9M for (54.5% of votes cast).
- 2022 Incentive Plan amended to increase authorized shares from 17M to 22M (82.0M for vs 5.8M against).
- Quorum of 118.4M shares (74.58%) represented at meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1001316/000143774925020335/0001437749-25-020335-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1001316/000143774925020335/tgtx20250613_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-020335

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer